The biggest gap is that we know relatively little about the real-world health effects of these peptides because most have not been studied in rigorous human clinical trials, Jason Nagata, M.D., associate professor of pediatrics at the University of California in the US, tells us
How could the ongoing investigation into the use of GLP-1 agonists for Type 1 diabetes shape future treatment options, and what ethical considerations might arise from prescribing these medications off-label
The short answer is yes, but there are specific techniques you should follow to ensure the medication works as intended
While semaglutide is excellent for appetite regulation and satiety, tirzepatide adds stronger metabolic effects, especially around insulin sensitivity and energy balance
It involves the buildup of toxic proteins that kill brain cells